MALDI imaging and in-source decay for top-down characterization of glioblastoma
Rima Ait-Belkacem1, Caroline Berenguer, Claude Villard
1Aix-Marseille Université Inserm, CRO2 UMR S-911, Marseille, France.
Abstract:
Glioblastoma multiforme is one of the most common intracranial tumors encountered in adults. This tumor of very poor prognosis is associated with a median survival rate of approximately 14 months. One of the major issues to better understand the biology of these tumors and to optimize the therapy is to obtain the molecular structure of glioblastoma. MALDI molecular imaging enables location of molecules in tissues without labeling. However, molecular identification in situ is not an easy task. In this paper, we used MALDI imaging coupled to in-source decay to characterize markers of this pathology. We provided MALDI molecular images up to 30 μm spatial resolution of mouse brain tissue sections. MALDI images showed the heterogeneity of the glioblastoma. In the various zones and at various development stages of the tumor, using our top-down strategy, we identified several proteins. These proteins play key roles in tumorigenesis. Particular attention was given to the necrotic area with characterization of hemorrhage, one of the most important poor prognosis factors in glioblastoma.
Insights
Matrix-assisted laser desorption/ionization (MALDI) molecular imaging identified key proteins and hemorrhage in glioblastoma, improving understanding of this aggressive brain tumor. This technique reveals tumor heterogeneity and potential therapeutic targets.
Area of Science:
- * Neuroscience
- * Molecular Biology
- * Medical Imaging
Background:
- * Glioblastoma multiforme is a prevalent and aggressive adult brain tumor with a poor prognosis.
- * Understanding glioblastoma's molecular structure is crucial for optimizing therapy.
- * Current methods for in situ molecular identification within tissues present challenges.
Purpose of the Study:
- * To characterize glioblastoma markers using MALDI imaging coupled with in-source decay.
- * To investigate the molecular heterogeneity of glioblastoma at high spatial resolution.
- * To identify proteins involved in tumorigenesis and analyze prognostic factors like hemorrhage.
Main Methods:
- * Utilized MALDI molecular imaging with in-source decay for label-free molecular analysis.
- * Generated MALDI molecular images with 30 μm spatial resolution from mouse brain tissue sections.
- * Employed a top-down strategy for protein identification within different tumor zones and stages.
Main Results:
- * Demonstrated the heterogeneity of glioblastoma through detailed molecular imaging.
- * Identified several proteins crucial for tumorigenesis across various tumor regions and developmental stages.
- * Characterized hemorrhage in necrotic areas, a significant poor prognosis factor.
Conclusions:
- * MALDI imaging coupled with in-source decay is effective for characterizing glioblastoma molecular markers.
- * The study revealed key proteins and pathological features, offering insights into glioblastoma biology.
- * This approach aids in understanding tumor heterogeneity and identifying potential therapeutic targets.
